Who is sponsoring NCT04423783?

NCT04423783 is sponsored by Anke Haberkamp.

What drugs are being tested in NCT04423783?

Interventions in NCT04423783: 7-day exposure therapy via self-developed app according to (Haberkamp et al., submitted), Therapist-guided one-session online exposure therapy according to (Öst, 1989).

What condition does NCT04423783 study?

NCT04423783 studies Spider Phobia.

Is NCT04423783 still recruiting?

NCT04423783 is currently completed. Last updated 8 November 2024.

Last reviewed 2024-11-08 · How we verify

NCT04423783

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Gamification in the Treatment of Spider Phobia

Completed NA Last updated 8 November 2024

What this trial tests

NA trial testing 7-day exposure therapy via self-developed app according to (Haberkamp et al., submitted) in Spider Phobia in 90 participants. Completed in 31 August 2024.

Timeline

1 July 2020

Primary endpoint
31 August 2024

31 August 2024

Quick facts

Lead sponsor	Anke Haberkamp
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	90
Start date	1 July 2020
Primary completion	31 August 2024
Estimated completion	31 August 2024
Sites	2 locations across Germany

Drugs / interventions tested

7-day exposure therapy via self-developed app according to (Haberkamp et al., submitted)
Therapist-guided one-session online exposure therapy according to (Öst, 1989)

Conditions studied

Spider Phobia — all drugs for Spider Phobia →

Sponsor

Anke Haberkamp

Who can join

Adults 18 to 65, any sex, with Spider Phobia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Mobile applications are more and more considered when implementing programs for treating mental disorders. The study aims to reduce avoidance and fear of spiders in spider-fearful individuals by combining exposure principles with gamification elements (e.g. narrative background, level progression, points, feedback). We investigate the efficacy of the gamified app in a remote online-therapy context.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04423783 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Anke Haberkamp
Last refreshed: 8 November 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04423783.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing